Magnetic Resonance Imaging Scans Articles

To assess the negative predictive value (NPV) of multi-parametric MRI (mpMRI) for detection of prostate cancer (PCa) in routine clinical practice, and to identify characteristics of patients for whom mpMRI fails to detect high-grade (Gleason ≥7) disease.

To compare the relative value of MRI in biopsy naïve patients to those with previous negative biopsy. Although MRI targeted biopsy has been studied in several major prostate cancer (PCa) cohorts (biopsy naïve, previous negative biopsy, active surveillance), the relative benefit in these cohorts has not been established.